[1] |
BIONDI B,COOPER D S.The clinical significance of subclinical thyroid dysfunction[J]. Endocr Rev,2008,29(1):76-131.
|
[2] |
RODONDI N,DEN ELZEN W P,BAUER D C,et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality[J]. JAMA,2010,304(12):1365-1374.
|
[3] |
MOLINARO S,IERVASI G,LORENZONI V,et al.Persistence of mortality risk in patients with acute cardiac diseases and mild thyroid dysfunction[J]. Am J Med Sci,2012,343(1):65-70.
|
[4] |
MARONGIU F,CAULI C,MARIOTTI S.Thyroid,hemostasis and thrombosis[J]. J Endocrinol Invest,2004,27(11):1065-1071.
|
[5] |
SQUIZZATO A,ROMUALDI E,BÜLLER H R,et al. Clinical review:thyroid dysfunction and effects on coagulation and fibrinolysis:a systematic review[J]. J Clin Endocrinol Metab,2007,92(7):2415-2420.
|
[6] |
HAK A E,POLS H A,VISSER T J,et al.Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women:the Rotterdam Study[J]. Ann Intern Med,2000,132(4):270-278.
|
[7] |
CANTÜRK Z,CETINARSLAN B,TARKUN I,et al. Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism[J]. Thyroid,2003,13(10):971-977.
|
[8] |
GULDIKEN S,DEMIR M,TURGUT B,et al.Global fibrinolytic capacity in patients with subclinical hypothyroidism[J]. Endocr J,2005,52(3):363-367.
|
[9] |
AKINCI B,COMLEKCI A,ALI OZCAN M,et al.Elevated thrombin activatable fibrinolysis inhibitor(TAFI) antigen levels in overt and subclinical hypothyroid patients were reduced by levothyroxine replacement[J]. Endocr J,2007,54(1):45-52.
|
[10] |
OZCAN M A,CÖMLEKCI A,DEMIRKAN F,et al. Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders[J]. Thromb Res,2003,110(4):243-247.
|
[11] |
KVETNY J,HELDGAARD P E,BLADBJERG E M,et al.Subclinical hypothyroidism is associated with a low-grade inflammation,increased triglyceride levels and predicts cardiovascular disease in males below 50 years[J]. Clin Endocrinol(Oxf),2004,61(2):232-238.
|
[12] |
EREM C.Blood coagulation,fibrinolytic activity and lipid profile in subclinical thyroid disease:subclinical hyperthyroidism increases plasma factor X activity[J]. Clin Endocrinol(Oxf),2006,64(3):323-329.
|
[13] |
陈宝炳,陈松,滕勇,等. 甲状腺功能减退患者血清同型半胱氨酸水平监测的意义[J]. 检验医学,2005,30(6):593-594.
|
[14] |
PIAZZE J,GIOIA S,CEREKJA A,et al.Doppler velocimetry alterations related to platelet changes in third trimester pregnancies[J]. Platelets,2007,18(1):11-15.
|
[15] |
FERNÁNDEZ-REAL J M,BROCH M,RICHART C,et al. CD14 monocyte receptor,involved in the inflammatory cascade,and insulin sensitivity[J]. J Clin Endocrinol Metab,2003,88(4):1780-1784.
|
[16] |
CHADAREVIAN R,BRUCKERT E,LEENHARDT L,et al.Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism[J]. J Clin Endocrinol Metab,2001,86(2):732-737.
|
[17] |
DI MINNO M N,PALMIERI V,LOMBARDI G,et al. Lack of change in insulin levels as a biological marker of PAI-1 lowering in GH-deficient adults on r-HGH replacement therapy[J]. Thromb Res,2009,124(6):711-713.
|
[18] |
DÖRR M,ROBINSON D M,WALLASCHOFSKI H,et al. Low serum thyrotropin is associated with high plasma fibrinogen[J]. J Clin Endocrinol Metab,2006,91(2):530-534.
|
[19] |
GALLUS A S,HIRSH J,GENT M.Relevance of preoperative and postoperative blood tests to postoperative leg-vein thrombosis[J]. Lancet,1973,2(7833):805-859.
|
[20] |
TRIPODI A,MANNUCCI P M.Activated partial thromboplastin time(APTT). New indications for an old test?[J]. J Thromb Haemost,2006,4(4):750-751.
|